Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

Francesco Mazziotta, MD, Gabriele Buda, MD PhD, Nadia Cecconi, MD, Giulia Cervetti, MD, Lorenzo Iovino, MD, Enrico Orciuolo, MD PhD, Matteo Pelosini, MD PhD, Edoardo Benedetti, MD, Francesco Caracciolo, MD, Giovanni Carulli, MD, Sara Galimberti, MD PhD, Mario Petrini, MD PhD

Blood (2019) 134 (Supplement_1): 3254.

https://doi.org/10.1182/blood-2019-126118

Published: 2019

Journal Articles

COO, MYC / BCL2 Status and R-IPI Define a Group of Poor Prognosis DLBCL Patients in a Real-World Clinical Setting

Stefania Bettelli, Raffaella Marcheselli, Samantha Pozzi, MD, Luigi Marcheselli, Robel Papotti, Elisa Forti, M. Christina Christina Cox, MD PhD, Arianna Di Napoli, Tamar Tadmor, MD, Antonino Maiorana, Valentina Donati, MD, Sara Galimberti, MD PhD, Stefano Sacchi, MD

Blood (2019) 134 (Supplement_1): 1617.

https://doi.org/10.1182/blood-2019-125689

Published: 2019

Journal Articles

Multicenter Validation of the Magnetic Resonance T2* Technique for Quantification of Pancreatic Iron

Alessia Pepe, MD, Laura Pistoia, Daniele De Marchi, Stefano Pulini, MD, Elena Facchini, MD, Nicola Dello Iacono, Aurelio Maggio, MD, Maria Grazia Bisconte, MD, Maria Paola Smacchia, Calogera Gerardi, MD, Nicolò Schicchi, Gennaro Restaino, Vincenzo Positano, Antonella Meloni, PhD

Blood (2018) 132 (Supplement 1): 3637.

https://doi.org/10.1182/blood-2018-99-110161

Published: 2018

Journal Articles

Combined Famd and ANOVA Investigation Leads to Significant Association Between the hOCT1/ABCB1 Diplotype and Both Efficacy and Tolerability in Patients Affected By Chronic Myeloid Leukemia

Sara Galimberti, MD, Laura Galeotti, Francesco Ceccherini, Dario Domingo, Marco Laurino, Marialuisa Polillo, Antonello Di Paolo, Claudia Baratè, MD, Carmen Fava, MD, Antonio D'Avolio, Giulia Fontanelli, Romano Danesi, Fulvio Cornolti, Francesca Guerrini, Elena Ciabatti, Giuseppe Saglio, MDPhD, Mario Petrini

Blood (2015) 126 (23): 4838.

https://doi.org/10.1182/blood.V126.23.4838.4838

Published: 2015

Journal Articles

Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?

Lara Aprile, Luca Puccetti, Sara Galimberti, Antonella Gozzini, Francesca Scarpini, Marzia Defina, Federica De Majo, Claudia Baratè, Anna Sicuranza, Veronica Candi, Barbara Scappini, Donatella Raspadori, Alessandro Gozzetti, Alberto Bosi, Mario Petrini, Monica Bocchia

Blood (2013) 122 (21): 1482.

https://doi.org/10.1182/blood.V122.21.1482.1482

Published: 2013

Journal Articles

Crystal Structure Of Tissue Factor Pathway Inhibitor (TFPI) Kunitz Domain 1 and 2 In Complex With An Inhibitory Cyclic Peptide,

Michael Dockal, PhD, Rudolf Hartmann, PhD, Markus Fries, PhD, Katerina Prohaska, Robert Pachlinger, PhD, Thomas Polakowski, PhD, Johannes Brandstetter, PhD, Jan Rosing, PhD, Friedrich Scheiflinger, PhD

Blood (2013) 122 (21): 453.

https://doi.org/10.1182/blood.V122.21.453.453

Published: 2013

Journal Articles

A Phase I Study of GA101 (RO5072759) Monotherapy Followed by Maintenance in Patients with Multiply Relapsed/Refractory CD20 + Malignant Disease.

Laurie H. Sehn, MD, MPH, Sarit E. Assouline, MD, Douglas A. Stewart, MD, Joy Mangel, MD, FRCPC, Pavel Pisa, MD, PhD, Jaimal Kothari, MD, Michael Crump, MD

Blood (2009) 114 (22): 934.

https://doi.org/10.1182/blood.V114.22.934.934

Published: 2009

Journal Articles

Incidence of Progressive Multifocal Leukoencephalopathy in Non-Hodgkin Lymphoma Patients Treated with Rituximab.

Daniele Focosi, M.D., Marco Tuccori, Pharm., D., Corrado Blandizzi, M.D., Mario Del Tacca, M.D., Mario Petrini, M.D., Ph.D.

Blood (2009) 114 (22): 3675.

https://doi.org/10.1182/blood.V114.22.3675.3675

Published: 2009

Journal Articles

Magnetic Resonance T2* Technique for Segmental and Global Quantification of Myocardial Iron : Multi-Centre Validation in the MIOT (Myocardial Iron Overload in Thalassemia) Network

Vincenzo Positano, MSc, Anna Ramazzotti, PhD, Alessia Pepe, MD, PhD, Cristina Salvatori, MSc, Paolo Marcheschi, MSc, Antonella Meloni, MSc, Maurizio Mangione, MSc, Maria Filomena Santarelli, PhD, Paolo Cianciulli, MD, Vincenzo Caruso, MD, Aurelio Maggio, MD, Luigi Landini, PhD, Massimo Lombardi, MD

Blood (2008) 112 (11): 5420.

https://doi.org/10.1182/blood.V112.11.5420.5420

Published: 2008

NARROW

The Impact of Different Mobilization Strategies in the Setting of Multiple Myeloma

COO, MYC / BCL2 Status and R-IPI Define a Group of Poor Prognosis DLBCL Patients in a Real-World Clinical Setting

Multicenter Validation of the Magnetic Resonance T2* Technique for Quantification of Pancreatic Iron

Combined Famd and ANOVA Investigation Leads to Significant Association Between the hOCT1/ABCB1 Diplotype and Both Efficacy and Tolerability in Patients Affected By Chronic Myeloid Leukemia

Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?

Crystal Structure Of Tissue Factor Pathway Inhibitor (TFPI) Kunitz Domain 1 and 2 In Complex With An Inhibitory Cyclic Peptide,

A Phase I Study of GA101 (RO5072759) Monotherapy Followed by Maintenance in Patients with Multiply Relapsed/Refractory CD20 + Malignant Disease.

Incidence of Progressive Multifocal Leukoencephalopathy in Non-Hodgkin Lymphoma Patients Treated with Rituximab.

Magnetic Resonance T2* Technique for Segmental and Global Quantification of Myocardial Iron : Multi-Centre Validation in the MIOT (Myocardial Iron Overload in Thalassemia) Network

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only